skip to main content
Give

Research

The Irma Lerma Rangel College of Pharmacy research is at the forefront of clinical discovery, focusing on multiple key areas including specialized pharmaceutical delivery and drug development, while leading diagnostic studies into cures for cancer and other chronic diseases that are prevalent in our world today.

Faculty research
phd program
grant awards
recent publications
Research Seminars
NEWS
Research opportunities
Postdoctoral Association
Research Colloquium

Opportunity Available to Pre-Review RO1 Applications

Faculty members are encouraged to utilize a pre-review process to have their R01 application edited by professional scientific writers and seek experts’ opinions. The Associate Dean for Research & Innovation will be responsible for contacting outside experts for their consultation to assist with the grant application. Faculties are encouraged to submit the complete application two months before the submission date to utilize this resource. Each faculty may use this opportunity once.

Research Focus Areas

Cardiovascular Diseases
Cancer

Drug Design & Discovery
Drug Delivery

Infectious Diseases
Medicinal Chemistry


Pharmacy Education & Pedagogy
Pharmacy Services

Bioavailability/Bioequivalence (BA/BE)

 

Contact

chendil-damodaranChendil Damodaran, PhD
Associate Dean of Research and Innovation
Texas A&M Rangel School of Pharmacy
159 Reynolds Medical Bldg., MS 1114
College Station, Texas 77843
Phone: 979.436.0495
chendamodar@tamu.edu

Research Resources

Pharmacy Practice

The Department of Pharmacy Practice uses evidence-based approaches to optimize the practice of pharmacy. Our research is focused on the promotion of health and well-being of patients by the generation, application and dissemination of knowledge relating to medications and medication use.

 

Pharmaceutical Sciences

The Department of Pharmaceutical Sciences has active researchers with funding from the NIH, FDA, DoD, several state and national foundations and the pharmaceutical industry. Our research spans the areas of cancer, diabetes, opioid/cannabinoids, drug delivery systems and formulations, manufacturing sciences, epigenetics, nanotechnology, 3D printing and emerging technologies among others.